Drug industry called for more R&D tax cut.

Published: 2005-05-02 06:57:00

Updated: 2005-05-02 06:57:00

The Korea Pharmaceutical Manufacturers Association (KPMA: chairman Kim Jeong-soo) proposed to the government authorities including the MOFE, MOHW, MOST and MOIE on April 27 that a tax privilege as prescribed in the special tax privilege law should extend to the pharmaceutical R&D.

The KPMA cla...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK